May 04, 2022 / 02:00PM GMT
Unidentified Company Representative -
Hello, everyone. Welcome to today's live webinar from IQVIA, CAR-T cell therapy, exploring dynamic market insights and future challenges.
Before we begin, a few important announcements. This webcast is designed to be interactive. We encourage you to ask questions during the event. (Operator Instructions) Slides will automatically advance throughout the event. If you have technical problems viewing or hearing this presentation, please click on the question mark help widget in the doc, at the bottom of your presentation window.
I would now like to introduce today's speakers. Dr. Karin Berger, and Dr. Nicole Friedersdorf. Dr. Friedersdorf is currently the Director of Global Oncology Product and Strategy at IQVIA Dr. Friedersdorf's oncology expertise is honed by 11 years of oncology experience within pharmaceutical companies, where she held positions in marketing, consulting, market research, medical affairs and medical communications.
She also has oncology research roles in her background, including 5 years as a researcher at renowned facilities, such
IQVIA Holdings Inc. - Special Call Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers